INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/10/2026
Back to search
Official data from USPTO
ASCELIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ASCELIA
ST13
US500000079232309Class
1, 5, 42, 44
Filing
79232309
Registration
5706074
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
06/11/2026
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
01/26/2018
Registration date
03/26/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/10/2025
Last transaction
06/11/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
SE
Examiner
BRADLEY, EVELYN
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Ascelia Pharma AB
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and science; chemical products for scientific purposes; biochemicals for in vitro and in vivo scientific use; chemicals for use in vitro scientific use
Class 5
Pharmaceuticalsmedical and veterinary preparations namelydiagnostic agentsdiagnostic reagentscontrast mediacontrast agents for use in medical diagnostic imaging in the nature of magnetic resonance imaging; contrast media and contrast agents for use in-vivo imaging; contrast media and contrast agents for use in vitro imaging
Class 42
Scientific and technological servicesresearch and design in the field of pharmaceuticalsmedical imaging; industrial analysis and research services in the field of pharmaceuticalsmedical imaging; bacteriological and biological research; conducting clinical trials for others; research and development of new products for others; scientific laboratory services
Class 44
Medical services; veterinary services; advisory and consulting services relating to the use of medical and diagnostic products in medical and medical diagnostic examination; advisory and consulting services relating to use of contrast media and contrast agents in medical and medical diagnostic examinations; advisory and consulting services relating to the use of medical and medical diagnostic imaging technologies; medical and medical diagnostic consulting services
Publications
History of USPTO decisions and trademark events.
35 publications found
C71T
CANCELLED SECTION 71
10/10/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/06/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/26/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/16/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/16/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/30/2019
FIMP
FINAL DISPOSITION PROCESSED
07/30/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/26/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
03/26/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/08/2019
PUBO
PUBLISHED FOR OPPOSITION
01/08/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/19/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/21/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
11/20/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/20/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
11/20/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/20/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
11/19/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/19/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
11/19/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/19/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/05/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/05/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/13/2018
RFNP
REFUSAL PROCESSED BY IB
06/30/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/06/2018
RFRR
REFUSAL PROCESSED BY MPU
06/06/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/27/2018
CNRT
NON-FINAL ACTION WRITTEN
05/26/2018
MAFR
APPLICATION FILING RECEIPT MAILED
05/26/2018
DOCK
ASSIGNED TO EXAMINER
05/22/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/22/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/18/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/17/2018
Continuous trademark protection
Get notified about every new filing that threatens ASCELIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.